Logo Logo
Help
Contact
Switch Language to German

Kruger, S.; Ormanns, S.; Rösgen, V.; Legenstein, M.-L.; Haas, M.; Westphalen, C. B.; Düwell, P.; Schnurr, M.; Heinemann, V.; Kirchner, T. and Böck, S. (2017): IDO1 expression as biomarker in erlotinib-treated patients with advanced pancreatic cancer: translational results from the AIO-PK0104 phase III trial. In: Oncology Research and Treatment, Vol. 40: p. 235

Full text not available from 'Open Access LMU'.

Actions (login required)

View Item View Item